glp 1 agonist fda approval just approved orforglipron (Foundayo), Eli Lilly's oral GLP-1 receptor for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest Novo Nordisk's Wegovy® pill (oral

Oxyresveratrol alleviates hepatic steatosis by activating AMPK and inhibiting SREBP-1cmediated lipogenesis, demonstrating anti-NAFLD efficacy comparable to atorvastatin in animal models (51)

Real-world impact of GLP-1 receptor agonists on endoscopic patient outcomes in an ambulatory setting: a retrospective study at a large tertiary center

Glutathione is a powerful antioxidant that can inhibit the production of melanin, the pigment responsible for skin color

Carnitine supplementation in human idiopathic asthenospermia: clinical results

Description Ipamorelin Vial Ipamorelin from Frontier Peptide Labs is supplied as a lyophilized (freeze-dried) powder in 5mg and 10mg vial formats, intended strictly for laboratory research use

Tirzepatide# Tirzepatide is a single 39-amino acid molecule that simultaneously activates GIP and GLP-1 receptors